Theriva™ biologics to participate in the bio-europe spring conference

Rockville, md., march 11, 2024 (globe newswire) -- theriva™ biologics (nyse american: tovx), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that company's management will provide a corporate update and participate in one-on-one meetings at the bio-europe spring conference, to be held in barcelona, spain from march 18-20, 2024.
TOVX Ratings Summary
TOVX Quant Ranking